These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30525590)

  • 1. Novel Strategies To Activate the Dopamine D
    Hall A; Provins L; Valade A
    J Med Chem; 2019 Jan; 62(1):128-140. PubMed ID: 30525590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics.
    Felsing DE; Jain MK; Allen JA
    Curr Top Med Chem; 2019; 19(16):1365-1380. PubMed ID: 31553283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes.
    Tice MA; Hashemi T; Taylor LA; Duffy RA; McQuade RD
    Pharmacol Biochem Behav; 1994 Nov; 49(3):567-71. PubMed ID: 7862709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Positive Allosteric Modulators of the D
    Luderman KD; Conroy JL; Free RB; Southall N; Ferrer M; Sanchez-Soto M; Moritz AE; Willette BKA; Fyfe TJ; Jain P; Titus S; Hazelwood LA; Aubé J; Lane JR; Frankowski KJ; Sibley DR
    Mol Pharmacol; 2018 Oct; 94(4):1197-1209. PubMed ID: 30068735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor.
    Wood M; Ates A; Andre VM; Michel A; Barnaby R; Gillard M
    Mol Pharmacol; 2016 Feb; 89(2):303-12. PubMed ID: 26655303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
    Conroy JL; Free RB; Sibley DR
    ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional differentiation of multiple dopamine D1-like receptors by NNC 01-0012.
    Sugamori KS; Hamadanizadeh SA; Scheideler MA; Hohlweg R; Vernier P; Niznik HB
    J Neurochem; 1998 Oct; 71(4):1685-93. PubMed ID: 9751203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D1 receptor mutagenesis: role of amino acids in agonist and antagonist binding.
    Tomic M; Seeman P; George SR; O'Dowd BF
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1020-7. PubMed ID: 8466481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activities and inverse agonism in dopamine receptors.
    Zhang B; Albaker A; Plouffe B; Lefebvre C; Tiberi M
    Adv Pharmacol; 2014; 70():175-214. PubMed ID: 24931197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances and challenges in the search for D
    Moritz AE; Free RB; Sibley DR
    Cell Signal; 2018 Jan; 41():75-81. PubMed ID: 28716664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes.
    Xiao P; Yan W; Gou L; Zhong YN; Kong L; Wu C; Wen X; Yuan Y; Cao S; Qu C; Yang X; Yang CC; Xia A; Hu Z; Zhang Q; He YH; Zhang DL; Zhang C; Hou GH; Liu H; Zhu L; Fu P; Yang S; Rosenbaum DM; Sun JP; Du Y; Zhang L; Yu X; Shao Z
    Cell; 2021 Feb; 184(4):943-956.e18. PubMed ID: 33571432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disorders.
    Svensson KA; Hao J; Bruns RF
    Adv Pharmacol; 2019; 86():273-305. PubMed ID: 31378255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.
    Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ
    Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational insights into diverse binding modes of the allosteric modulator and their regulation on dopamine D1 receptor.
    Chen J; Song Y; Ma L; Jin Y; Yu J; Guo Y; Huang Y; Pu X
    Comput Biol Med; 2024 May; 173():108283. PubMed ID: 38552278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel M(1) allosteric ligands: a patent review.
    Kuduk SD; Beshore DC
    Expert Opin Ther Pat; 2012 Dec; 22(12):1385-98. PubMed ID: 23092292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-(Fluoromethoxy)-4'-(
    García-Cárceles J; Vázquez-Villa H; Brea J; Ladron de Guevara-Miranda D; Cincilla G; Sánchez-Martínez M; Sánchez-Merino A; Algar S; Teresa de Los Frailes M; Roberts RS; Ballesteros JA; Rodríguez de Fonseca F; Benhamú B; Loza MI; López-Rodríguez ML
    J Med Chem; 2022 Sep; 65(18):12256-12272. PubMed ID: 36044544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Molecular Mechanism of Positive Allosteric Modulation at the Dopamine D1 Receptor.
    Goldberg A; Xie B; Shi L
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
    Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
    Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.